The utility of molecular genetic techniques in craniosynostosis cases associated with intellectual disability

Abstract Molecular genetic testing in craniosynostosis leads to the detection of the mutations in the genes encoding fibroblast growth factor receptors (FGFR), providing information about the etiology of the genetic disorder. Muenke syndrome is produced by p.Pro250Arg mutation in FGFR3 gene with evidence of variable expressivity, representing 8% of the syndromic craniosynostoses. Here, we present the identification of a p.Pro250Arg pathogenic mutation (c.749C>G) in the FGFR3 gene using Multiplex Ligation-dependent Probes Amplification (MLPA) analysis in conjunction with Sanger sequencing in a patient with craniosynostosis and mild intellectual disability. The MLPA analysis detected a reduced signal of the probe, at the site of the c.749C>G mutation, defined by the presence of one allele of C749>G mutation in the FGFR3 gene, exon 7. Sanger sequencing was performed for confirmation and identified heterozygous p.Pro250Arg pathogenic variant (c.749C>G) in exon 7 of the FGFR3. In conclusion, we assessed the validity and clinical utility of the combined molecular genetic techniques, MLPA analysis, and Sanger sequencing, for craniosynostosis and intellectual disability, improving not only the diagnostic testing but also the genetic counseling and management of the disorder.

[1]  L. Negură,et al.  Sanger sequencing of MMR genes in a one-plate system , 2018 .

[2]  P. Ros Pérez,et al.  [Muenke syndrome]. , 2020, Anales de pediatria.

[3]  N. Brown,et al.  A craniosynostosis massively parallel sequencing panel study in 309 Australian and New Zealand patients: findings and recommendations , 2017, Genetics in Medicine.

[4]  Steven A. Wall,et al.  Clinical genetics of craniosynostosis , 2017, Current opinion in pediatrics.

[5]  H. Skirton,et al.  A Qualitative Study to Explore the Views and Attitudes towards Prenatal Testing in Adults Who Have Muenke Syndrome and their Partners , 2017, Journal of Genetic Counseling.

[6]  J. Hurst,et al.  Diagnostic value of exome and whole genome sequencing in craniosynostosis , 2016, Journal of Medical Genetics.

[7]  K. Dipple,et al.  Genetic Screening in Patients with Craniofacial Malformations , 2016, Journal of Pediatric Genetics.

[8]  K. Boycott,et al.  Concordance between whole‐exome sequencing and clinical Sanger sequencing: implications for patient care , 2016, Molecular genetics & genomic medicine.

[9]  Yonit A. Addissie,et al.  Muenke syndrome: An international multicenter natural history study , 2016, American journal of medical genetics. Part A.

[10]  S. Twigg,et al.  A Genetic-Pathophysiological Framework for Craniosynostosis. , 2015, American journal of human genetics.

[11]  J. Richtsmeier,et al.  Closing the Gap: Genetic and Genomic Continuum from Syndromic to Nonsyndromic Craniosynostoses , 2014, Current Genetic Medicine Reports.

[12]  L. Butnariu,et al.  Detection of chromosomal imbalances using combined MLPA kits in patients with syndromic intellectual disability , 2014 .

[13]  Nicholas Katsanis,et al.  Molecular genetic testing and the future of clinical genomics , 2013, Nature Reviews Genetics.

[14]  S. Bartlett,et al.  Phenotype profile of a genetic mouse model for Muenke syndrome , 2012, Child's Nervous System.

[15]  U. Hehr Molecular Genetic Testing of Patients with Craniosynostosis , 2011 .

[16]  M. Muenke,et al.  Craniosynostoses : molecular genetics, principles of diagnosis, and treatment , 2011 .

[17]  S. Yoon,et al.  A Korean Family with the Muenke Syndrome , 2010, Journal of Korean medical science.

[18]  Luis Fernando González Escobar,et al.  Significant phenotypic variability of Muenke syndrome in identical twins , 2009, American journal of medical genetics. Part A.

[19]  S. Rasmussen,et al.  A population‐based study of craniosynostosis in metropolitan Atlanta, 1989–2003 , 2008, American journal of medical genetics. Part A.

[20]  E. Zackai,et al.  Muenke syndrome (FGFR3‐related craniosynostosis): Expansion of the phenotype and review of the literature , 2007, American journal of medical genetics. Part A.

[21]  E. Haan,et al.  A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. , 1997, American journal of human genetics.

[22]  E. Zackai,et al.  Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes , 1996, Nature Genetics.